BMI's 18.55% short interest is remarkably elevated for a $4.5B cap company, suggesting significant bearish conviction despite the stock trading 25.9x earnings—a premium valuation that would typically invite profit-taking. The RSI of 36.8 indicates oversold conditions, creating potential mean-reversion appeal, yet the persistently high short ratio hints that skeptics see structural or cyclical headwinds ahead. The gap between valuation ambitions and current weakness warrants scrutiny: either shorts are positioning ahead of disappointing earnings, or the stock has been punished too severely relative to fundamentals. Either way, the compression between elevated shorts and depressed technicals sets up a volatile squeeze scenario.
Snapshot
Recent headlines
Peers in Totalizing Fluid Meters & Counting Devices
Build a thesis around BMI
Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.
Open in AlgoThesis →